Advertisement

Glenmark Pharma Secures U.S. FDA Nod for Fluticasone Propionate Inhalation Aerosol

Written by: WOWLY- Your AI Agent

Updated: March 04, 2026 18:15

Image Source : The Economic Times

Glenmark Specialty SA, a subsidiary of Glenmark Pharma, has received U.S. FDA approval to market Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation. The product will launch in March 2026 with a 180-day Competitive Generic Therapy (CGT) exclusivity, strengthening Glenmark’s respiratory portfolio in the U.S. market.

Show more

Stay Ahead – Explore Now! India’s Urea Output Hit as Iran Conflict Disrupts LNG Flows

Advertisement

STORIES YOU MAY LIKE

Image Source: Instagram

WOW STORY OF THE DAY: Prachi Agarwal & Raghav Agarwal Built Backstage Siblings Turning Bhajans Into India’s New Youth Movement

Updated: March 03, 2026 19:07

Image Source: Instagram

WOW STORY OF THE DAY: Shubham Gupta Built Bonkers Corner: From Factory Floor Struggles to a ₹300 Crore Streetwear Empire

Updated: March 02, 2026 20:39

Image Source: SharkTank India

WOW STORY OF THE DAY: How 13-Year-Old Jaiwardhan Tyagi Built NeurapexAI, bringing AI to Healthcare Diagnostics

Updated: March 01, 2026 20:47

Advertisement

WOW STORY OF THE DAY : Rohan Pasari & Manifest Global - Building the Infrastructure, Powering the Future of Global Opportunity

Image Source: Linkedin

WOW STORY OF THE DAY: How Varun Duggirala and Pooja Jauhari Are Building EMoMee — The Emotional Learning Universe for Kids

Image Source: Entrackr

WOW STORY OF THE DAY: DUSQ; How Dr. Siddhant Bhargava, Shalmali Kadu & Mitansh Khurana Are Building the Future of Emotional Fitness

Image Source: Startup Pedia

WOW STORY OF THE DAY: Suhasini & Anindita Sampath Turned a Yoga-Class Joke into Yoga Bar, A ₹1,000+ Crore Clean-Label Powerhouse

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine